Best Kinase Inhibitor for cholangiocarcinoma
2 Kinase Inhibitor drugs indicated for cholangiocarcinoma, ranked by our independent rating. The current highest-rated is lytgobi. Compare them with all treatments for cholangiocarcinoma or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Top kinase inhibitor for cholangiocarcinoma: 1. Lytgobi · 2. Pemazyre
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Lytgobi | Not yet rated | Prescription | — | View → |
| 2 | Pemazyre | Not yet rated | Prescription | — | View → |
Full ranking · 2 drugs
lytgobi
PrescriptionFDA-sourced
Kinase Inhibitor used to treat cholangiocarcinoma.
kinase inhibitorcholangiocarcinoma
Price varies
pemazyre
PrescriptionFDA-sourced
Frequently asked
- What is the best kinase inhibitor for cholangiocarcinoma?
- By our independent rating, lytgobi currently ranks highest among Kinase Inhibitor drugs used for cholangiocarcinoma. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which kinase inhibitor drugs treat cholangiocarcinoma?
- pharmaranks lists 2 Kinase Inhibitor products indicated for cholangiocarcinoma, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.